A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Cancer Drug News FDA approves pralsetinib for lung cancer with RET gene fusions September 14, 2020 The Food and Drug Administration granted accelerated approval to pralsetinib for adult patients with metastatic…